Q:l Describel thel pathophysiologyl ofl rheumatoidl arthritisl RA:

Q:l Describel thel pathophysiologyl ofl rheumatoidl arthritisl (RA):

A)l RAl involvesl chronicl autoimmunel inflammationl andl tissuel damagel inl thel joints.B)l RAl isl al virall infectionl thatl affectsl thel liver.C)l RAl primarilyl causesl symptomsl inl thel digestivel tract.D)l RAl isl anl acutel bacteriall infection.

Answer:

A)l RAl involvesl chronicl autoimmunel inflammationl andl tissuel damagel inl thel joints.

Q:l Whatl isl al commonl symptoml ofl Hepatitisl Cl inl itsl chronicl stage?

A)l Numbnessl inl limbs B)l Severel abdominall pain C)l Fatiguel andl poorl appetite D)l Frequentl headaches

Answer:

C)l Fatiguel andl poorl appetite

Q:l Whichl ofl thel followingl isl al characteristicl ofl specialtyl medications?

A)l Lowl cost B)l Easilyl accessiblel atl alll pharmacies C)l Complexl treatmentl regimensl requiringl ongoingl monitoring D)l Lackl ofl speciall handlingl orl storagel requirements

Answer:

BIOLl 351/l BIOL351l Modulesl 9,10 &

Final Exams:l (Latestl 2026/l 2027l

Update)l 100%l Verifiedl Questionsl &l Answersl |l Gradel A 1 / 3

Answer:l C)l Complexl treatmentl regimensl requiringl ongoingl monitoring

Q:l Whol mayl definel whatl isl consideredl al specialtyl medicationl forl reimbursementl purposes?

A)l Thel patient B)l Thel manufacturer C)l Payersl (insurancel companies) D)l Thel pharmacist

Answer:

Answer:l C)l Payersl (insurancel companies)

Q:l Specialtyl medicationsl arel ________l derivedl andl availablel inl injection,l infusion,l orl orall form.

Answer:

biologically

Q:l Truel orl False:l Specialtyl medicationsl arel typicallyl lowl cost.

Answer:

False

Q:l Truel orl False:l Adalimumabl (Humira)l isl administeredl asl anl intravenousl (IV)l infusionl everyl otherl week.

Answer:

Falsel (It'sl al subcutaneousl injectionl everyl otherl week)

Q:l Whatl doesl Bevacizumabl (Avastin)l targetl tol treatl metastaticl colorectall cancer? 2 / 3

Answer:

Vascularl endotheliall growthl factor

Q:l Whichl classl ofl drugl doesl Infliximabl (Remicade)l belongl to?

A)l Anti-TNFl monoclonall antibody B)l Interleukinl receptorl antagonist C)l Selectivel costimulationl modulator D)l Humanl recombinantl IL-2l analogue

Answer:

Answer:l A)l Anti-TNFl monoclonall antibody

Q:l Whichl drugl isl indicatedl forl thel treatmentl ofl metastaticl renall celll carcinomal orl melanoma?

A)l Adalimumabl (Humira) B)l Aldesleukinl (Proleukin) C)l Etanerceptl (Enbrel) D)l Abataceptl (Orencia)

Answer:

Answer:l B)l Aldesleukinl (Proleukin)

Q:l Natalizumabl (Tysabri)l worksl byl targetingl whichl partl ofl thel immunel system?

A)l Tumorl necrosisl factorl (TNF) B)l Interleukin-1l receptor C)l Vascularl endotheliall growthl factor D)l Alpha4l integrinl subunit

Answer:

Answer:l D)l Alpha4l integrinl subunit

• / 3